Annals of Clinical and Translational Neurology

Article	Citations
Issue Information	111
Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels	84
The case of a 49‐year‐old man with involuntary toe movements	75
Structural and functional connectivity alteration patterns of the cingulate gyrus in Type 2 diabetes	68
Association of serum Spp1 levels with disease progression in ALS and SBMA	59
ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression	59
Brain imaging signatures in amyotrophic lateral sclerosis: Correlation with peripheral motor degeneration	56
Peripheral nervous system manifestations of MOG antibody associated disease	56
Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation	53
Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan	52
Incremental clinical value of intraplaque neovascularization in predicting recurrent ischemic stroke	47
Blended phenotype of TECPR2‐associated hereditary sensory‐autonomic neuropathy and Temple syndrome	42
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long‐term outcome study	41
Cognitive impairment in pulmonary arterial hypertension	41
Discrepant expressive language lateralization in children and adolescents with epilepsy	38
Consistency of electrical source imaging in presurgical evaluation of epilepsy across different vigilance states	36
High‐dose IgG suppresses local inflammation and facilitates functional recovery after olfactory system injury	36
Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients	36
Order from chaos: Using CSF proteomics to predict ALS progression	36
Muscle magnetic resonance imaging involvement patterns in nemaline myopathies	35
A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica	34
Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA	34
Exhaustive clinical examination of etiology and initial response to first‐line treatment in 577 children with infantile epileptic spasm syndrome children: A 5‐year retrospective observational study	33
SARS‐CoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis	33
Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB/D	33

Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes	33
Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia	33
Issue Information	32
Cocaine use is associated with cerebral white matter hyperintensities in HIV disease	32
Comparison between mono‐tacrolimus and mono‐glucocorticoid in the treatment of myasthenia gravis	32
The case of a 60‐year‐old man with decline in job performance and changes in personality and judgment	31
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)	31
Dose–exposure–efficacy response of intravenous immunoglobulin G 10% in multifocal motor neuropathy	31
Vascular endothelial‐cadherin as a marker of endothelial injury in preclinical Alzheimer disease	30
Predictors of mTICI 2c/3 over 2b in patients successfully recanalized with mechanical thrombectomy	30
Corrigendum: Genome sequencing in persistently unsolved white matter disorders	30
Clinical scales in autoimmune encephalitis—A retrospective monocentric cohort study	29
Cerebral Amyloid Angiopathy Is Associated With Higher R2 Relaxation Rate: An MRI and Pathology Study	29
Visceral and emotional responses to direct electrical stimulations of the cortex	28
Intracranial plaque with large lipid core is associated with embolic stroke of undetermined source	28
Correlation of slow‐wave sleep with motor and nonmotor progression in Parkinson's disease	28
Plasma β‐synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical and adjuvant therapy	28
Prolonged venous transit is associated with worse neurological recovery in successfully reperfused large vessel strokes	27
Cerebellar impulsivity–compulsivity assessment scale	27
Early spinal muscular atrophy treatment following newborn screening: A 20‐month review of the first Italian regional experience	27
Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone	27
A potential biomarker of cognitive impairment: The olfactory dysfunction and its genes expression	26
Exosomal circ‐AHCY promotes glioblastoma cell growth via Wnt/β‐catenin signaling pathway	26
Diagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid‐β PET Retention	25
Association between air pollution and CSF sTREM2 in cognitively normal older adults: The CABLE study	25
Clinicoserological insights into patients with immune checkpoint inhibitor‐induced myasthenia gravis	25
Horizontal gaze palsy with progressive scoliosis: Further expanding the ROBO3 spectrum	24
Issue Information	24
Epidural stimulation with locomotor training ameliorates unstable blood pressure after tetraplegia. A case report	24
Intrinsic and extrinsic contributors to subregional thalamic volume loss in multiple sclerosis	24
Comprehensive assessment reveals numerous clinical and neurophysiological differences between MECP2‐allelic disorders	24
Identification of potential biomarkers for neuromyelitis optica by quantitative proteomics	23
Issue Information	23
COVID‐19 and the risk of Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis	23
Issue Information	23
Cortical networks of parkinsonian gait: a metabolic and functional connectivity study	23
Autoimmune brainstem encephalitis: Clinical associations, outcomes, and proposed diagnostic criteria	23
Issue Information	23
Transcranial pulse stimulation in the treatment of mild neurocognitive disorders	23
Adult‐onset rapidly worsening progressive myoclonic epilepsy caused by a novel variant in DHDDS	22
Topiramate dosage optimization for effective antiseizure management via population pharmacokinetic modeling	22
Laser interstitial thermal therapy in the management of bottom‐of‐sulcus dysplasia‐related epilepsy	22
The systemic inflammation markers as possible indices for predicting respiratory failure and outcome in patients with myasthenia gravis	21
Progressive Myoclonus Epilepsy: Distinctive MRI Changes in Cerebellar and Motor Networks	21
TRPV4 mutations causing mixed neuropathy and skeletal phenotypes result in severe gain of function	21
Long‐term continuation of anti‐seizure medications after acute stroke	21
Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease	20
CSF cytokine, chemokine and injury biomarker profile of glial fibrillary acidic protein (GFAP) autoimmunity	20
Clinical utility of diffusion MRI‐derived measures of cortical microstructure in a real‐world memory clinic setting	20
Issue Information	20

Retina as a potential biomarker for the early stage of Alzheimer's disease spectrum	20
The Comparative Effectiveness and Tolerability of Sphingosine‐1‐Phosphate Receptor Modulators in Patients With Multiple Sclerosis: A Network Meta‐Analysis of Randomized Controlled Trials	19
Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease	19
A machine learning approach to predict quality of life changes in patients with Parkinson's Disease	19
Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features	19
Machine learning models for outcome prediction in thrombectomy for large anterior vessel occlusion	19
Voxel‐based dysconnectomic brain morphometry with computed tomography in Down syndrome	19
Liraglutide for idiopathic intracranial hypertension: a real‐world propensity score‐matched study	19
Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis	19
Quantitative determination of SLC2A1 variant functional effects in GLUT1 deficiency syndrome	19
Gut microbiome is associated with multiple sclerosis activity in children	19
Combining structural and metabolic markers in a quantitative MRI study of motor neuron diseases	19
Modifiable factors associated with Huntington's disease progression in presymptomatic participants	18
Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy	18
A novel autosomal dominant ERLIN2 variant activates endoplasmic reticulum stress in a Chinese HSP family	18
Intravenous tirofiban following successful reperfusion in intracranial large artery atherosclerotic stroke: A secondary analysis of a randomized clinical trial	18
The case of an 85‐year‐old female with acute right hemiparesis with status epilepticus	18
Exercise training alters autoimmune cell invasion into the brain in autoimmune encephalomyelitis	18
Circulating Interleukin‐6 Levels and Timing of Acute Ischemic Stroke Onset	18
Cerebello‐Prefrontal Connectivity Underlying Cognitive Dysfunction in Spinocerebellar Ataxia Type 2	18
RETRACTION: Mechanism of ARPP21 antagonistic intron miR‐128 on neurological function repair after stroke	17
Ethnoracial disparities in gray matter atrophy are mediated by structural disconnectivity in multiple sclerosis	17
Real‐world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis	17
Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti‐CD20 therapy	17
Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy	17
Issue Information	17
	17
Benchmarking the proteomic profile of animal models of mesial temporal epilepsy	17
Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large‐Scale Exome Sequencing	17
Temporal lobe epilepsy surgery: Piriform cortex resection impacts seizure control in the long‐term	17
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis	17
	17
Correction to “Neurofilament light chain levels in cerebrospinal fluid as a sensitive biomarker for cerebral adrenoleukodystrophy”	17
A PANoptosis‐Based Signature for Survival and Immune Predication in Glioblastoma Multiforme	17
Comparison of plasma and CSF biomarkers in predicting cognitive decline	17
Infliximab in neurosarcoidosis: a systematic review and meta‐analysis	16
A different pattern of clinical, muscle pathology and brain MRI findings in MELAS with mt‐ND variants	16
Tofersen treatment leads to sustained stabilization of disease in SOD1 ALS in a “real‐world” setting	16
Innovative technology‐based interventions in Parkinson's disease: A systematic review and meta‐analysis	16
Differential impact on motor unit characteristics across severities of adult spinal muscular atrophy	16
Mutation and clinical analysis of the CLCC1 gene in amyotrophic lateral sclerosis patients from Central South China	16
LRRK2 and Parkinson's disease: from genetics to targeted therapy	16
Relation of CDC42, Th1, Th2, and Th17 cells with cognitive function decline in Alzheimer's disease	16
Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy	16
Mitochondrial dysfunction in brain tissues and Extracellular Vesicles Fragile X‐associated tremor/ataxia syndrome	15
Longitudinal serum neurofilament light kinetics in post‐anoxic encephalopathy	15
A 14‐Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's	15
Optical genome mapping: Unraveling complex variations and enabling precise diagnosis in dystrophinopathy	15
Remyelination varies between and within lesions in multiple sclerosis following bexarotene	15
Phenotyping Healthcare Use 2–3 Decades Before the First Multiple Sclerosis Demyelinating Event	15
Non‐neurological factors associated with serum neurofilament levels in the United States population	15
L1CAM variants cause two distinct imaging phenotypes on fetal MRI	15
	15
Clinical, genetic, and molecular characteristics in a central‐southern Chinese cohort of genetic leukodystrophies	15
Power training alters somatosensory cortical activity of youth with cerebral palsy	15
Nanopore 16S sequencing enhances the detection of bacterial meningitis after neurosurgery	15
CIDP/autoimmune nodopathies with nephropathy: a case series study	15
	15
Observational study of medical marijuana as a treatment for treatment‐resistant epilepsies	15
Scientific rationale for a higher dose of nusinersen	14
Management and Outcomes in Confirmed or Suspected Acute Symptomatic Seizure: Role of Structured Outpatient Care	14
A machine‐learning approach for predicting impaired consciousness in absence epilepsy	14
Recognizing early MRI signs (or their absence) is crucial in diagnosing metachromatic leukodystrophy	14
Occurrence, Risk Factors, and Prognosis of Acute Cerebral Microinfarcts in CADASIL	14
Chitotriosidase is a biomarker for adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia	14
Odor identification predicts the transition of patients with isolated RBD: A retrospective study	14
After early mTICI 2b, stop or continue? Insights from the PERSIST Registry	14
Argatroban plus alteplase in posterior versus anterior circulation stroke	14
Longitudinal changes of SARA scale in Friedreich ataxia: Strong influence of baseline score and age at onset	13
The Road Not Taken: Misclassifying an Anti‐Seizure Medication as a Failure	13
The Multiple Sclerosis Treatment Optimization Program	13
Long‐term safety and efficacy of stenting on correcting internal jugular vein and cerebral venous sinus stenosis	13
Evolution of neurologic symptoms in non‐hospitalized COVID‐19 “long haulers”	13
4‐Octyl itaconate inhibits inflammation via the NLRP3 pathway in neuromyelitis optica spectrum disorders	13
Distinctive cell‐free DNA methylation characterizes presymptomatic genetic frontotemporal dementia	13
“Brain age” predicts disability accumulation in multiple sclerosis	13
Dual‐Phase C‐11 PiB PET Images for Detecting Tau Pathology in Cerebral Amyloid Angiopathy	13
Pupillary dynamics predict long‐term outcome in a cohort of acute traumatic brain injury coma patients	13
Downregulation of SF3B2 protects CNS neurons in models of multiple sclerosis	13
Upregulation of RCAN1.4 by HIF1α alleviates OGD‐induced inflammatory response in astrocytes	13

Onasemnogene‐abeparvovec administration to premature infants with spinal muscular atrophy	13
Patient Selection in Deep Brain Stimulation: A Role for Transcranial Direct Current Stimulation to Enhance the Levodopa Challenge?	13
Sensitivity and specificity of the Salzburg EEG criteria for nonconvulsive status epilepticus	12
Baseline systolic blood pressure, hypertension history, and efficacy of remote ischemic conditioning	12
Natural history and survival rate of familial amyloidosis with polyneuropathy: A nationwide databank	12
T1−/T2‐weighted ratio reveals no alterations to gray matter myelination in temporal lobe epilepsy	12
WiTNNess: An international natural history study of infantile‐onset TNNT1 myopathy	12
Safety, pharmacokinetics, and pharmacodynamics of nomlabofusp (CTI‐1601) in Friedreich's ataxia	12
Heart meets brain: A 25‐year‐old with a constellation of neurologic symptoms and heart failure	12
Endovascular thrombectomy versus medical management on outcomes with infarct volumes more than 70 mL	12
Evaluating brain damage in multiple sclerosis with simultaneous multi‐angular‐relaxometry of tissue	12
Optimized microburst VNS elicits fMRI responses beyond thalamic‐specific response from standard VNS	12
Psychotropic medication use and Parkinson's disease risk amongst older women	12
Characterizing mortality in patients with AQP4‐Ab+ neuromyelitis optica spectrum disorder	12
Phase 1, First‐In‐Human, Single‐/Multiple‐Ascending Dose Study of Iluzanebart in Healthy Volunteers	12
SCAR32: Functional characterization and expansion of the clinical‐genetic spectrum	12
Glycated hemoglobin A1c, cerebral small vessel disease burden, and disease severity in Parkinson's disease	12
Well‐being on supportive techniques in amyotrophic lateral sclerosis: from neurologists' perspective	12
Neurological diagnoses in hospitalized COVID‐19 patients during the B.1.1.529 surge	12
B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity	12
Spatiotemporal spinal cord stimulation with real‐time triggering exoskeleton restores walking capability: a case report	12
Clinicopathological and circulating cell‐free DNA profile in myositis associated with anti‐mitochondrial antibody	11
ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis	11
Childhood‐onset progressive dystonia associated with pathogenic truncating variants in CHD8	11
Safety and efficacy of intravenous thrombolytic therapy in the extended window up to 24 hours: A systematic review and meta‐analysis	11
Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia	11
A contemporary review of therapeutic and regenerative management of intracerebral hemorrhage	11
Issue Information	11
B‐cell depletion limits HTLV‐1‐infected T‐cell expansion and ameliorate HTLV‐1‐associated myelopathy	11
An MRI assessment of mechanisms underlying lesion growth and shrinkage in multiple sclerosis	11
Capturing what matters: Patient‐reported LGI1‐ANTibody encephalitis outcome RatiNg scale (LANTERN)	11
Cortical signature of depressive symptoms in frontotemporal dementia: A surface‐based analysis	11
	11
Correction to “Efgartigimod for Generalized Myasthenia Gravis: A Multicenter Real‐World Cohort Study in China”	11
Lipid levels and the risk of dementia: A dose–response meta‐analysis of prospective cohort studies	11
Women's reproductive traits and ischemic stroke: a two‐sample Mendelian randomization study	11
Adult‐onset leukoencephalopathy caused by CSF1R mutations: Is all that glitters gold?	11
White matter microstructures in Parkinson's disease with and without impulse control behaviors	11
Social impact of brain fog and analysis of risk factors: Long COVID in Japanese population	11
Interaction between sex and neurofilament light chain on brain structure and clinical severity in Huntington’s disease	11
Repeated iv anti‐CD20 treatment in multiple sclerosis: Long‐term effects on peripheral immune cell subsets	11
Using electronic health data to explore effectiveness of ICU EEG and anti‐seizure treatment	11
Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcome	11
Novel Phenotypes and Deep Intronic Variant Expand TH‐Associated Dopa‐Responsive Dystonia Spectrum	11
First‐ever acute ischemic strokes in HIV‐infected persons: A case–control study from stroke units	10
Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study	10
Issue Information	10
Pharmacological perturbation reveals deficits in D2 receptor responses in Thap1 null mice	10
Using chronic recordings from a closed‐loop neurostimulation system to capture seizures across multiple thalamic nuclei	10
Efficacy and safety of combined low‐dose rituximab regimen for chronic inflammatory demyelinating polyradiculoneuropathy	10
Transcriptome analysis of collagen VI‐related muscular dystrophy muscle biopsies	10
Psoriasis and dementia: A population‐based matched cohort study of adults in England	10
Impact of lipid profiles on parenchymal hemorrhage and early outcome after mechanical thrombectomy	10
SARS‐COV‐2 a trigger of myelin oligodendrocyte glycoprotein‐associated disorder	10
Does long‐term phenytoin have a place in Dravet syndrome?	10
Efficacy of melatonin in term neonatal models of perinatal hypoxia‐ischaemia	10
Before attributing encephalomyelitis to SARS‐CoV‐2 vaccinations thoroughly exclude differentials	10
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia	10
Blood–brain barrier profile pretreatment is associated with hemorrhagic transformation after endovascular reperfusion	10
Erratum to “Inferring Disease Course From Differential Exon Usage in the Wide Titinopathy Spectrum”	10
Emerging variants, unique phenotypes, and transcriptomic signatures: an integrated study of COASY‐associated diseases	10
CD163+ macrophage density in perimysial connective tissue associated with prognosis in IMNM	10
Genetic spectrum in a cohort of patients with distal hereditary motor neuropathy	10
Music Interventions in Hyperacute and Acute Stroke Patients: A Randomized Controlled Pilot Feasibility Study	10
The neural correlates of topographical disorientation—a lesion analysis study	10
Seroprevalence of anti‐myelin oligodendrocyte glycoprotein antibodies in adults with myelitis	10
Axonal injury, sleep disturbances, and memory following traumatic brain injury	10
Homozygous variant in COQ7 causes autosomal recessive hereditary spastic paraplegia	10
Disorder of consciousness: Structural integrity of brain networks for the clinical assessment	10
Association of the time of day of EVT with clinical outcomes and benefit from successful recanalization after stroke	10
Mutations in the tail and rod domains of the neurofilament heavy‐chain gene increase the risk of ALS	9
Case of a 57‐year‐old woman with acute confusion and inability to recognize her husband	9
Remaining Burden of Spinal Muscular Atrophy Among Treated Patients: A Survey of Patients and Caregivers	9
Altered brain perfusion and oxygen levels relate to sleepiness and attention in post‐COVID syndrome	9
Correspondence of MRI and nTMS With EDSS in Multiple Sclerosis: Longitudinal Follow‐Up Study	9
Long‐term clinical, imaging and cognitive outcomes association with MS immunopathology	9
Clinical heterogeneity in a family with flail arm syndrome and review of hnRNPA1‐related spectrum	9
Resting‐state fMRI functional connectome of C9orf72 mutation status	9
Amyloidogenicity assessment of transthyretin gene variants	9
Associative cued asynchronous BCI induces cortical plasticity in stroke patients	9
Precision‐Optimised Post‐Stroke Prognoses	9
Insular cortex Hounsfield units predict postoperative neurocardiogenic injury in patients with aneurysmal subarachnoid hemorrhage	9
Inappropriate interpretation of non‐pathogenic HTRA1 variant as pathogenic	9
Copy number variations across the blood–brain barrier in multiple sclerosis	9
Preemptive dual therapy for children at risk for infantile‐onset spinal muscular atrophy	9
Loneliness as neurobehavioral issue in amyotrophic lateral sclerosis	9
Observational Study of Tocilizumab in Children With Febrile Infection‐Related Epilepsy Syndrome	9
Characteristics and outcome of facial nerve palsy from Lyme neuroborreliosis in the United States	9
Expanding the phenotypic spectrum of BCS1L‐related mitochondrial disease	9
Rapidly progressive dementia: Extending the spectrum of GFAP‐astrocytopathies?	9
Diffusion spectrum imaging predicts hippocampal sclerosis in mesial temporal lobe epilepsy patients	9
The role of m6A‐modified CircEPHB4 in glioma pathogenesis: Insights into cancer stemness metastasis	9
Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients	9
Nuclear pore pathology underlying multisystem proteinopathy type 3‐related inclusion body myopathy	9
Neurofilament light chain levels predict encephalopathy and outcome in community‐acquired pneumonia	9